scholarly journals Inpatient Management of Pulmonary Embolism: Clinical Characteristics and Mortality in a High-Volume Tertiary Care Center

2022 ◽  
Author(s):  
Harsha V. Mudrakola ◽  
Sean M. Caples ◽  
Robert J. Hyde ◽  
Robert D. McBane II ◽  
Sumera R. Ahmad
Keyword(s):  
Pulmonary Embolism ◽  
Clinical Characteristics ◽  
Care Center ◽  
Tertiary Care ◽  
High Volume ◽  
Tertiary Care Center ◽  
Inpatient Management

Clinical characteristics and risk factors of pulmonary embolism: data from a Saudi tertiary-care center

2013 ◽  
Vol 11 (2) ◽  
pp. 388-390 ◽  
Author(s):  
F. H. AlGAHTANI ◽  
N. BAYOUMI ◽  
A. ABDELGADIR ◽  
N. AL-NAKSHABANDI ◽  
Z. AL ASERI ◽  
...  
Keyword(s):  
Risk Factors ◽  
Pulmonary Embolism ◽  
Clinical Characteristics ◽  
Care Center ◽  
Tertiary Care ◽  
Tertiary Care Center

scholarly journals Prevalence and risk factors of anemia among pregnant women attending a high-volume tertiary care center for delivery

2015 ◽  
Vol 16 (4) ◽  
pp. 231-236 ◽  
Author(s):  
Cuneyt Eftal Taner ◽  
Atalay Ekin ◽  
Ulas Solmaz ◽  
Cenk Gezer ◽  
Birgul Cetin ◽  
...  
Keyword(s):  
Risk Factors ◽  
Pregnant Women ◽  
Care Center ◽  
Tertiary Care ◽  
High Volume ◽  
Tertiary Care Center

Effect of the SARS-CoV-2 Pandemic on the Experience and Outcomes of Patients Who Underwent Resection for Pancreatic Cancer at a High-volume Tertiary Care Center

2021 ◽  
Vol 233 (5) ◽  
pp. e117
Author(s):  
Rachel C. Kim ◽  
Alexandra M. Roch ◽  
Eugene P. Ceppa ◽  
Attila Nakeeb ◽  
C. Max Schmidt ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Care Center ◽  
Tertiary Care ◽  
High Volume ◽  
Tertiary Care Center

scholarly journals 468 Clinical characteristics, etiology, and treatment of erythema multiforme at a tertiary care center

2020 ◽  
Vol 140 (7) ◽  
pp. S62
Author(s):  
G. Shi ◽  
B. Kaffenberger ◽  
Y. Semenov ◽  
J. Choi ◽  
K. Williams ◽  
...  
Keyword(s):  
Erythema Multiforme ◽  
Clinical Characteristics ◽  
Care Center ◽  
Tertiary Care ◽  
Tertiary Care Center

scholarly journals 1696. Epidemiology, Clinical Characteristics and Outcomes of Invasive Aspergillosis in a Tertiary Care Hospital in Mexico

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S621-S621
Author(s):  
Carla Marina Román-Montes ◽  
María F Gonzalez-Lara ◽  
Alfredo Ponce de Leon ◽  
Maria O Valenzuela-Almada ◽  
Andrea Rangel-Cordero
Keyword(s):  
Liver Failure ◽  
Invasive Aspergillosis ◽  
Clinical Characteristics ◽  
Care Center ◽  
Tertiary Care ◽  
Solid Organ ◽  
Cell Transplant ◽  
Care Hospital ◽  
Tertiary Care Center ◽  
Eortc Criteria

Abstract Background Invasive aspergillosis is an important cause of life-threatening infection in immunocompromised patients. The objective was to describe the epidemiology, clinical characteristics, and outcome of patients with invasive aspergillosis (IA) in a tertiary care center in Mexico. Methods A laboratory-based survey was done to identify patients with positive Aspergillus culture or galactomannan from 2014 to 2018. The medical records were reviewed to include patients with proven and probable IA, according to the EORTC criteria. Descriptive analysis of clinical characteristics and risk factors for 6-week mortality was made through X2, T-test or Mann–Whitney test. A multivariate logistic regression model including variables with a P-value of <0.2 in univariate analysis was made. Results 240 cases of IA were identified: 193 (80%) probable, 27 (11%) proven, and 20 (8.3%) not meeting the EORTC criteria but considered infection. 53% were male, median age was 44 years (IQR 28–58), 78 (32.5%) had acute leukemia (AL), 42 (17.5%) hematological neoplasia, 29 (12%) hematopoietic stem-cell transplant (HSCT), 25 (10.4%) solid-organ transplant and 44 (18.3%) autoimmune diseases, 17.5% patients with AL underwent induction remission chemotherapy of which 31% received antifungal prophylaxis. Among patients with IA, 183 (82%) had a positive galactomannan and 109 (45%) had a culture with Aspergillus. Eleven had > 1 species: 55/120 (46%) were A. fumigatus, 18 (15%) A. niger and 18 (15%) A. flavus. Pulmonary disease occurred in 214 (89%). 212 patients (88%) received antifungal treatment with a median duration of 42 days (IQR 20–42). 129 (61%) received voriconazole (VRC), 20 (8.3%) Amphotericin B and 20(8.3%) were randomized to a posaconazole vs. VRC trial. Six-week mortality was 35% (n = 85). Lymphopenia (OR 3.6; 95% CI 1.4–9.0), liver failure (OR 3.3; 95% CI 1.7–6.5) and older age (OR 1.03; 95% CI 1.01–1.05) (marginally) were independently associated with increased 6-week mortality. Conclusion 240 patients with IA were identified in a 5-year period in a tertiary care center. Most had hematological neoplasias and low prevalence of antimold prophylaxis due to economical reasons. Six-week mortality was 35%, nonsurvivors had liver failure and lymphopenia more often. Increased awareness to prevent IA is needed. Disclosures All authors: No reported disclosures.

ERCP quality indicators: The experience of a high-volume tertiary care center in Saudi Arabia

2019 ◽  
Vol 20 (1) ◽  
pp. 32-37
Author(s):  
Shahem Abbarh ◽  
Mostafa Seleem ◽  
Areej Al Balkhi ◽  
Abdullah Al Mtawa ◽  
Abdullah Al Khathlan ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Quality Indicators ◽  
Care Center ◽  
Tertiary Care ◽  
High Volume ◽  
Tertiary Care Center
Sign in / Sign up

Export Citation Format

Share Document